Претраживање
Приказ резултата 1-2 од 2
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
(Elsevier Science Inc, New York, 2020)
Background More than a third of patients with epilepsy are treatment resistant, and thus new, more effective therapies to achieve seizure freedom are needed. Cenobamate (YKP3089), an investigational antiepileptic drug, has ...
Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures Reply
(Elsevier Science Inc, New York, 2020)